Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

By Aragon-Ching Jeanny   Ning Yang-Min   Chen Clara   Latham Lea   Guadagnini Jean-Pierre   Gulley James   Arlen Philip   Wright John   Parnes Howard   Figg William   Dahut William  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 221-226

Informa Healthcare

Access to resources Recommend Favorite

Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study

By Perrotta I.   Cristofaro M. G.   Amantea M.   Russo E.   De Fazio S.   Zuccalà V.   Conforti F.   Amorosi A.   Donato G.   Tripepi S.   Giudice M.  

Ultrastructural Pathology, Vol. 34, Iss. 4, 2010-08 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

The Phenomenon of Osteonecrosis of the Jaw in Patients with Metastatic Breast Cancer

By Poznak Catherine  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 110-112

Informa Healthcare

Access to resources Recommend Favorite

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis

By Ortega Cinzia   Montemurro Filippo   Faggiuolo Roberto   Vormola Roberto   Nanni Daniela   Goia Franco   Gilardino Marco Ottavio   Aglietta Massimo  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 664-668

Informa Healthcare

Access to resources Recommend Favorite

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

By Coleman R.  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite